Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016355237> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2016355237 endingPage "560" @default.
- W2016355237 startingPage "555" @default.
- W2016355237 abstract "The combination of lenalidomide, bortezomib and dexamethasone (RVD) has shown excellent efficacy in patients with relapsed or refractory multiple myeloma (RRMM). The aim of our study was to assess the efficacy and toxicity profile of RVD for patients with advanced RRMM. We retrospectively reviewed the records of all patients with RRMM treated with RVD between March 2009 and December 2011. Thirty patients received ≥1 full cycle of RVD. Primary endpoints were overall response rate (ORR), progression-free survival (PFS) and overall survival (OS). After a median of 5 cycles (1–16), a very good partial response (VGPR) was seen in 10%, partial response (PR) in 36.7% and stable disease (SD) in 13.3% (ORR of 46.7%). Disease progression occurred in 21 patients at a median of 3 months (range 1.41–4.59). Eight patients (26%) experienced grade 3/4 adverse events, including anemia, neutropenia, muscle weakness and pneumonia. No patient experienced worsening peripheral neuropathy. Although RVD has been previously shown to be effective in RRMM, the ORR and PFS we observed were affected by very advanced disease status and heavy prior exposure to novel agents. Nevertheless, six of these patients with RRMM experienced a benefit of ≥6 months, suggesting synergism of this immunomodulatory derivative/proteasome inhibitor combination and/or re-establishment of drug sensitivity by an emergent myeloma clone." @default.
- W2016355237 created "2016-06-24" @default.
- W2016355237 creator A5003338851 @default.
- W2016355237 creator A5034837494 @default.
- W2016355237 creator A5043490010 @default.
- W2016355237 creator A5045418082 @default.
- W2016355237 creator A5067291402 @default.
- W2016355237 creator A5082712392 @default.
- W2016355237 date "2013-01-02" @default.
- W2016355237 modified "2023-10-17" @default.
- W2016355237 title "Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for heavily pretreated relapsed or refractory multiple myeloma" @default.
- W2016355237 cites W1980471295 @default.
- W2016355237 cites W2003734726 @default.
- W2016355237 cites W2032597319 @default.
- W2016355237 cites W2033585196 @default.
- W2016355237 cites W2033887959 @default.
- W2016355237 cites W2044436186 @default.
- W2016355237 cites W2056586434 @default.
- W2016355237 cites W2060496777 @default.
- W2016355237 cites W2078611063 @default.
- W2016355237 cites W2108318793 @default.
- W2016355237 cites W2111732928 @default.
- W2016355237 cites W2118112957 @default.
- W2016355237 cites W2121283512 @default.
- W2016355237 cites W2126528859 @default.
- W2016355237 cites W2133986577 @default.
- W2016355237 cites W2142149038 @default.
- W2016355237 cites W2162468902 @default.
- W2016355237 cites W2169774815 @default.
- W2016355237 cites W2980039687 @default.
- W2016355237 cites W97512070 @default.
- W2016355237 doi "https://doi.org/10.3109/10428194.2012.719614" @default.
- W2016355237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22881043" @default.
- W2016355237 hasPublicationYear "2013" @default.
- W2016355237 type Work @default.
- W2016355237 sameAs 2016355237 @default.
- W2016355237 citedByCount "10" @default.
- W2016355237 countsByYear W20163552372014 @default.
- W2016355237 countsByYear W20163552372015 @default.
- W2016355237 countsByYear W20163552372016 @default.
- W2016355237 countsByYear W20163552372017 @default.
- W2016355237 countsByYear W20163552372021 @default.
- W2016355237 crossrefType "journal-article" @default.
- W2016355237 hasAuthorship W2016355237A5003338851 @default.
- W2016355237 hasAuthorship W2016355237A5034837494 @default.
- W2016355237 hasAuthorship W2016355237A5043490010 @default.
- W2016355237 hasAuthorship W2016355237A5045418082 @default.
- W2016355237 hasAuthorship W2016355237A5067291402 @default.
- W2016355237 hasAuthorship W2016355237A5082712392 @default.
- W2016355237 hasConcept C126322002 @default.
- W2016355237 hasConcept C141071460 @default.
- W2016355237 hasConcept C143998085 @default.
- W2016355237 hasConcept C197934379 @default.
- W2016355237 hasConcept C2776063141 @default.
- W2016355237 hasConcept C2776364478 @default.
- W2016355237 hasConcept C2777063308 @default.
- W2016355237 hasConcept C2777478702 @default.
- W2016355237 hasConcept C2779609412 @default.
- W2016355237 hasConcept C2780401358 @default.
- W2016355237 hasConcept C29730261 @default.
- W2016355237 hasConcept C71924100 @default.
- W2016355237 hasConcept C90924648 @default.
- W2016355237 hasConceptScore W2016355237C126322002 @default.
- W2016355237 hasConceptScore W2016355237C141071460 @default.
- W2016355237 hasConceptScore W2016355237C143998085 @default.
- W2016355237 hasConceptScore W2016355237C197934379 @default.
- W2016355237 hasConceptScore W2016355237C2776063141 @default.
- W2016355237 hasConceptScore W2016355237C2776364478 @default.
- W2016355237 hasConceptScore W2016355237C2777063308 @default.
- W2016355237 hasConceptScore W2016355237C2777478702 @default.
- W2016355237 hasConceptScore W2016355237C2779609412 @default.
- W2016355237 hasConceptScore W2016355237C2780401358 @default.
- W2016355237 hasConceptScore W2016355237C29730261 @default.
- W2016355237 hasConceptScore W2016355237C71924100 @default.
- W2016355237 hasConceptScore W2016355237C90924648 @default.
- W2016355237 hasIssue "3" @default.
- W2016355237 hasLocation W20163552371 @default.
- W2016355237 hasLocation W20163552372 @default.
- W2016355237 hasOpenAccess W2016355237 @default.
- W2016355237 hasPrimaryLocation W20163552371 @default.
- W2016355237 hasRelatedWork W1699374300 @default.
- W2016355237 hasRelatedWork W1988784378 @default.
- W2016355237 hasRelatedWork W2090603150 @default.
- W2016355237 hasRelatedWork W2128903704 @default.
- W2016355237 hasRelatedWork W2165065963 @default.
- W2016355237 hasRelatedWork W2192430028 @default.
- W2016355237 hasRelatedWork W2330049167 @default.
- W2016355237 hasRelatedWork W2339661511 @default.
- W2016355237 hasRelatedWork W2400769328 @default.
- W2016355237 hasRelatedWork W2403269090 @default.
- W2016355237 hasVolume "54" @default.
- W2016355237 isParatext "false" @default.
- W2016355237 isRetracted "false" @default.
- W2016355237 magId "2016355237" @default.
- W2016355237 workType "article" @default.